EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische StudieOpen Access · CC BY 4.0

Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study

Vivek Y Reddy iD, Rahul Doshi iD, James E Ip iD, Pascal Defaye iD, Derek V Exner, Robert Canby, Morio Shoda iD, Maria G Bongiorni iD, Gerhard Hindricks iD, Petr Neužil iD, Thomas Callahan iD, Nima Badie iD und 2 weitere

Europace · 03.06.2025 · 27 (6)

DOI: 10.1093/europace/euaf074 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Europace, online erschienen am 06.06.2025. Verfasst von Vivek Y Reddy und 13 weiteren Autor:innen. Beteiligte Einrichtung: Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, 1190 5th Ave, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Electric Power Supplies, Cardiac Pacing, Artificial, Arrhythmias, Cardiac. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A dual-chamber leadless pacemaker (LP) system that employs distinct atrial and ventricular LP devices (ALP, VLP) has been introduced to clinical practice. Proprietary, low-energy, implant-to-implant (i2i) communication at each beat enables the devices to maintain synchronous atrioventricular sensing and pacing. We evaluated device longevities and contributing factors, such as i2i communication. Methods and results Patients meeting dual-chamber pacing indications received the dual-chamber LP system as part of a prospective, multi-centre, international clinical trial (Aveir DR i2i Study, NCT05252702). Programming and diagnostics were interrogated from all de novo, non-revised, dual-chamber programmed devices at 12 months post-implant. This analysis included 302 patients (65% male; age 70 ± 13 years; weight 80 ± 19 kg; intrinsic heart rate 55 ± 7 bpm; 58% sinus node dysfunction, 27% atrioventricular block). At 12 months, devices were programmed to dual-chamber pacing (DDD(R) or DDI(R)) at a median 60 bpm rate, median 1.25 V pulse amplitude in ALP and 1.5 V in VLP, median 0.4 ms pulse width, and median i2i signal setting level 5 out of 7. Median ALP and VLP remaining battery longevities at 12 months were 4.3 and 9.1 years, with median total ALP and VLP longevities of 5.3 and 9.9 years. Base rate, pulse amplitude, pacing percentage, event rate, impedance, and i2i setting level all exhibited significant correlations with ALP and VLP longevities (P < 0.001). Programming i2i setting levels below 7 produced the greatest longevity savings.

Conclusion

The first dual-chamber LP demonstrated adequate projected battery longevity after 12 months of use. Patient-specific device programming considerations, unique to leadless devices, may extend longevity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialElectric Power SuppliesCardiac Pacing, ArtificialArrhythmias, CardiacHumansMaleFemaleAgedProspective StudiesEquipment DesignAged, 80 and overMiddle AgedTime FactorsHeart RateTreatment OutcomeAtrioventricular Block

Stichwörter der Autor:innen

AveirBattery longevityDual-chamberLeadless pacemaker

Autor:innen und Institutionen

  • Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, 1190 5th Ave, New York, NY 10029, USA.
  • Department of Clinical Cardiac Electrophysiology, HonorHealth Cardiac Arrhythmia Group, Scottsdale, AZ, USA.
  • Department of Cardiology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA.
  • Department of Cardiology and Vascular Medicine, CHRU Albert Michallon, Grenoble, France.
  • Department of Cardiac Sciences, Foothills Medical Centre, Calgary, Canada.
  • Department of Cardiology, Texas Cardiac Arrhythmia Institute, Austin, TX, USA.

ORCID-Profile: Vivek Y Reddy, Rahul Doshi, James E Ip, Pascal Defaye, Morio Shoda, Maria G Bongiorni, Gerhard Hindricks, Petr Neužil, Thomas Callahan, Nima Badie, Matthew G Fishler, Reinoud E Knops

Förderung

  • Abbott

Zitieren

APA

Reddy, V. Y., Doshi, R., Ip, J. E., Defaye, P., Exner, D. V., Canby, R., Shoda, M., Bongiorni, M. G., Hindricks, G., Neužil, P., Callahan, T., Badie, N., Fishler, M. G., & Knops, R. E. (2025). Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study. Europace, 27(6). https://doi.org/10.1093/europace/euaf074

Vancouver

Reddy VY, Doshi R, Ip JE, Defaye P, Exner DV, Canby R, et al. Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study. Europace. 2025;27(6). doi:10.1093/europace/euaf074

BibTeX
@article{Reddy2025,
  author = {Reddy, Vivek Y and Doshi, Rahul and Ip, James E and Defaye, Pascal and Exner, Derek V and Canby, Robert and Shoda, Morio and Bongiorni, Maria G and Hindricks, Gerhard and Neužil, Petr and Callahan, Thomas and Badie, Nima and Fishler, Matthew G and Knops, Reinoud E},
  title = {Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study},
  journal = {Europace},
  year = {2025},
  volume = {27},
  number = {6},
  doi = {10.1093/europace/euaf074}
}
Kostenlos starten →